Mainstay Medical's ReActiv8 receives CE Mark: 3 points

Mainstay Medical received CE Mark approval for ReActiv8, its implantable neurostimulation system.

Here are three points:

1. ReActiv8 aims to provide chronic low back pain relief in adults who have attempted medical management and physical therapy.

2. The CE Mark allows Mainstay Medical to commercialize ReActiv8 in Europe.

3. Mainstay Medical will initially focus its sales and marketing efforts in Germany.